Cargando…

The Application of Dopamine Combined with Intravenous Furosemide Infusion Therapy Has an Apparent Clinical Effect in Treating Patients with Heart Failure

OBJECTIVE: To observe the efficacy and safety of dopamine plus furosemide in treating patients with heart failure. METHODS: This research included 150 patients with heart failure who were diagnosed and treated at our hospital between March 2018 and November 2020. The patients were randomly assigned...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Jinzheng, Wang, Rui, Qin, Shaoqiang, Zhang, Zhanshuai, Li, Huixian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410776/ https://www.ncbi.nlm.nih.gov/pubmed/36034940 http://dx.doi.org/10.1155/2022/1055160

Ejemplares similares

Retracted: The Application of Dopamine Combined with Intravenous Furosemide Infusion Therapy Has an Apparent Clinical Effect in Treating Patients with Heart Failure
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Ambulatory intravenous furosemide for decompensated heart failure: safe, feasible, and effective
por: Ahmed, Fozia Z., et al.
Publicado: (2021)

Intravenous furosemide in decompensated heart failure: do not protocolize dosing but the desired effect!
por: de Grooth, Harm-Jan S, et al.
Publicado: (2014)

Evaluation of diuretic efficiency of intravenous furosemide in patients with advanced heart failure in a heart failure clinic
por: Herrera-Leaño, Nancy, et al.
Publicado: (2023)

Effects of intravenous furosemide plus small‐volume hypertonic saline solutions on markers of heart failure
por: Tuttolomondo, Antonino, et al.
Publicado: (2021)

Association of time‐to‐intravenous furosemide with mortality in acute heart failure: data from REPORT‐HF
por: Ouwerkerk, Wouter, et al.
Publicado: (2022)

Increased mortality in elderly heart failure patients receiving infusion of furosemide compared to elderly heart failure patients receiving bolus injection
por: Sager, Rana, et al.
Publicado: (2020)

Continuous infusion of furosemide versus intermittent boluses in acute decompensated heart failure: Effect on thoracic fluid content
por: Ragab, Dalia, et al.
Publicado: (2018)

Furosemide infusion in children with dengue fever and hypoxemia
por: Bharath Kumar Reddy, K. R., et al.
Publicado: (2014)

‘Door-to-furosemide’ timing: early treatment of heart failure
por: Piazza, Vito
Publicado: (2019)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
por: Velat, Ivan, et al.
Publicado: (2020)

Comparison of continuous infusion and intermittent boluses of furosemide in acute heart failure: A protocol for systematic review and meta-analysis
por: Wang, Tao, et al.
Publicado: (2021)

Efficacy and Safety of Subcutaneous Infusion of Non-formulated Furosemide in Patients with Worsening Heart Failure: a Real-World Study
por: Civera, Jose, et al.
Publicado: (2021)

A Pharmacogenetic Investigation of Intravenous Furosemide in Decompensated Heart Failure: A Meta-Analysis of 3 Clinical Trials
por: de Denus, Simon, et al.
Publicado: (2016)

Oral Furosemide and Hydrochlorothiazide/Amiloride versus Intravenous Furosemide for the Treatment of Resistant Nephrotic Syndrome
por: Frățilă, Georgiana, et al.
Publicado: (2023)

Intravenous furosemide vs nebulized furosemide in patients with pulmonary edema: A randomized controlled trial
por: Barzegari, Hasan, et al.
Publicado: (2021)

A Fast and Validated HPLC Method for Simultaneous Determination of Dopamine, Dobutamine, Phentolamine, Furosemide, and Aminophylline in Infusion Samples and Injection Formulations
por: Chen, Fuchao, et al.
Publicado: (2021)

Addition of Tolvaptan Compared With Increased Dose of Furosemide in Heart Failure Patients With Chronic Kidney Disease Under Furosemide Treatment
por: Tanaka, Toshiki, et al.
Publicado: (2018)

Effects of levosimendan/furosemide infusion on Plasma Brain Natriuretic Peptide, echocardiographic parameters and cardiac output in end-stage heart failure patients
por: Feola, Mauro, et al.
Publicado: (2011)

Effect of continuous furosemide infusion on outcome of acute kidney injury
por: Ni, Jie, et al.
Publicado: (2019)

Proteomic differences among patients with heart failure taking furosemide or torsemide
por: Cooper, Lauren B., et al.
Publicado: (2022)

Clinical effects of combined treatment by optimal dose of furosemide and spironolactone on diastolic heart failure in elderly patients
por: CHEN, ZHI-HAO, et al.
Publicado: (2016)

Activation of heme-free soluble guanylate cyclase with cinaciguat has beneficial cardiorenal actions when added to furosemide in experimental heart failure
por: Boerrigter, Guido, et al.
Publicado: (2011)

An exploratory study with an adaptive continuous intravenous furosemide regimen in neonates treated with extracorporeal membrane oxygenation
por: van der Vorst, Maria MJ, et al.
Publicado: (2007)

Effects of Intravenous Infusion of Dopamine on Tumor Blood Flow in Rat Subcutis
por: Tanda, Shigeru, et al.
Publicado: (1994)

A new paradigm for the treatment of volume overload in heart failure-combined effect of tolvaptan with furosemide
por: Okamoto, Hiroshi
Publicado: (2013)

Effect of Hypertonic Saline Solution Combined with Furosemide on Acute Heart Failure: A Meta-Analysis
por: Li, Zuoqing, et al.
Publicado: (2022)

Subcutaneous Furosemide in Heart Failure: Pharmacokinetic Characteristics of a Newly Buffered Solution
por: Sica, Domenic A., et al.
Publicado: (2018)

Association of early administration of furosemide with improved oxygenation in patients with acute heart failure
por: Mikami, Takafumi, et al.
Publicado: (2021)

A retrospective evaluation of the efficacy of intravenous bumetanide and comparison of potency with furosemide
por: Nappi, Jean M.
Publicado: (2013)

Comparison of Different Furosemide Regimens in the Treatment of Acute Heart Failure: A Meta-Analysis
por: Huang, Youpan, et al.
Publicado: (2022)

Outcome Predictors and Safety of Home Dobutamine Intravenous Infusion in End Stage Heart Failure Patients
por: Jobbé-Duval, Antoine, et al.
Publicado: (2021)

Effects of acute systemic dehydration promoted by intravenous furosemide on respiratory mucus in dogs
por: Nakagawa, NK, et al.
Publicado: (2001)

Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure
por: Jujo, Kentaro, et al.
Publicado: (2016)

Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study
por: Rahhal, Alaa, et al.
Publicado: (2019)

Continuous versus intermittent use of furosemide in patients with heart failure and moderate chronic renal dysfunction
por: Zheng, Zhigui, et al.
Publicado: (2021)

Shenfu injection combined with furosemide in the treatment of chronic heart failure in patients with coronary heart disease: A protocol of randomized controlled trial
por: Gao, Yibing, et al.
Publicado: (2021)

Short-Term Intravenous Sodium Nitrite Infusion Improves Cardiac and Pulmonary Hemodynamics in Heart Failure Patients
por: Ormerod, Julian O.M., et al.
Publicado: (2015)

Intravenous iron infusion in patients with heart failure: a systematic review and study‐level meta‐analysis
por: Salah, Husam M., et al.
Publicado: (2023)

Tolvaptan vs. furosemide‐based diuretic regimens in patients hospitalized for heart failure with hyponatremia (AQUA‐AHF)
por: Ng, Tien M.H., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e2ue4ks3t0cn0oiustaqdgpbc3